dc.date.accessioned2022-02-01T21:18:29Z
dc.date.available2022-02-01T21:18:29Z
dc.date.created2022-02-01T21:18:29Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/11331
dc.identifierhttps://doi.org/10.1002/art.41980
dc.description.abstractRheumatologic and musculoskeletal diseases (RMDs) are important causes of morbidity and mortality worldwide. The World Health Organization (WHO) considers musculoskeletal conditions to be the leading causes of disability worldwide, and the greatest independent contributors to chronic pain. Population-based surveys from low- and middlbe income countries (LMICs) have demostrated similar rates of RMDs compared with high-income countries. However, in many low-resource settings rheumatology remains underdeveloped with regard to health care access, clinical practice, education, training and research...
dc.languageeng
dc.publisherWiley
dc.relationArthritis and Rheumatology
dc.relation2326-5205
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectRheumatology
dc.subjectFrontiers
dc.subjectChallenges
dc.subjectOpportunities
dc.titleGlobal Rheumatology Research: Frontiers, Challenges, and Opportunities.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución